10x Genomics, Inc. (TXG) › Cost of Revenue10x Genomics, Inc. (TXG) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2017: $10.56M2018: $28.66M2019: $61.03M2020: $58.47M2021: $74.09M2022: $120.39M2023: $209.41M2024: $196.30M2025: $198.94M$198.94M2017Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$198.94M+1.3%2024$196.30M-6.3%2023$209.41M+74.0%2022$120.39M+62.5%2021$74.09M+26.7%2020$58.47M-4.2%2019$61.03M+112.9%2018$28.66M+171.4%2017$10.56M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share